| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.42B | +7.3% |
| Cost of Revenue | $200.7M | +4.6% |
| R&D Expense | $85.7M | +6.4% |
| SG&A Expense | $195.4M | +3.7% |
| Operating Income | $943.1M | +8.8% |
| Interest Expense | $75.3M | -9.6% |
| Pre-tax Income | $880.2M | +12.5% |
| Income Tax | $206.4M | +8005.0% |
| Net Income | $673.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $373.6M | +67.2% |
| Short-term Investments | $606.8M | -38.2% |
| Accounts Receivable | $6.2M | +17.3% |
| Current Assets | $1.04B | -18.1% |
| Total Assets | $1.73B | -12.6% |
| Current Liabilities | $1.12B | +4.0% |
| Total Liabilities | $3.30B | +1.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $831.1M | +3.0% |
| Capital Expenditures | $27.4M | -48.3% |
| Investing Cash Flow | $355.7M | +232.1% |
| Financing Cash Flow | -$1.04B | -44.0% |
| Free Cash Flow | $803.7M | +6.6% |
| -14.1% |
| EPS (Basic) | $6.24 | -11.0% |
| EPS (Diluted) | $6.24 | -10.9% |
| Stockholders' Equity |
| -$1.56B |
| -23.9% |